People
Sir Mene Pangalos said the company was considering not submitting it to the FDA if it finds it is “banging its head against a brick wall indefinitely.”
Biopharma and life sciences companies continue to strengthen their executive teams and boards with this week’s Movers & Shakers.
In his new book, Warp Speed, Paul Mango said the realization that many healthcare workers didn’t want the vaccine, for instance, was shocking.
Robert Hollingsworth, PhD, a former Pfizer executive who oversaw the development of cancer vaccines and immunotherapeutics, has taken on the role of the CSO at Shoreline Biosciences.
BioSpace talked with Paul Mango, one of the key leaders of Operation Warp Speed, about the experience.
Cambridge Crossing will enable innovative drug discovery platforms for chemistry, protein engineering, structural and synthetic biology, among other key modalities.
More than two dozen people were given the opportunity to confront members of the Sackler family in a virtual environment and share the impactful pain opioid addiction caused their families.
Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers
Bancel reaped the rewards of SpikeVax’s success, but the Boston Business Journal noted that annual compensation for Moderna’s median employee plunged 16%.
Two months after he received a gene-edited pig heart, David Bennett Sr. has died. He was 57.
PRESS RELEASES